• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/63

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

63 Cards in this Set

  • Front
  • Back
a. Where are chylomicrons formed?
i. Intestinal epithelial cells
ii. Assembled in Golgi apparatus
b. Where are nascent chylomicrons secreted?
i. Into lymph
ii. apoA proteins
iii. apoB-48
c. What do chylomicrons accumulate in the blood stream?
i. apoC and apoE from HDL
d. What is LPL’s effect on chylomicrons?
i. Removes TAG-- chylomicrons become smaller
e. How are phospholipids transferred to HDL?
i. PLTP
f. What components of chylomicrons are transferred to HDL?
i. Surface molecules→
1. Phospholipid
2. Cholesterol
3. apoA and apoC
g. After losing its surface components, what do chylomicrons gain from HDL?
i. More apoE
ii. Cholesteryl ester
h. What clears chylomicron remnants from blood?
i. LDL binds apoE
ii. LRP
iii. Both in liver
i. When are chylomicrons present in the blood?
i. After a meal
ii. ½ life is less than 1 hours
j. What is the distribution of chylomicrons to the body tissues?
i. 80% to heart, adipose and muscle
ii. 20% to liver
a. Where are VLDL and LDL synthesized?
i. Liver
b. What are the steps of VLDL and LDL synthesis?
i. Lipids assembled in ER
ii. Apoproteins synthesized in RER
iii. VLDL assembled in Golgi
iv. Secreted into bloodstream as nascent VLDL
c. What does VLDL acquire from HDL in the bloodstream?
i. apoC
ii. apoE
d. What removes TAGs from VLDL?
i. LPL
e. What causes VLDL to become smaller?
i. apoC, phospholipids, and TAGs transferred to HDL
f. What do VLDL remnants acquire in the bloodstream?
i. Choelsteryl ester
g. How is VLDL/IDL removed from the bloodstream?
i. LDL (B100/E) receptor in liver
ii. 50% of IDL cleared by liver
h. What happens to the 50% of IDL not cleared by the liver?
i. It is converted to LDL
ii. Becomes anchored to HL→ removal of TAG and phospholipids
iii. ApoE is transferred to HDL
i. How many molecules of apoB100 does LDL contain?
i. 1
j. What is the half-life of plasma LDL?
i. Up to several days
k. How is LDL cleared from the blood?
i. LDL receptor
ii. LRP receptor
iii. In liver (70%)
l. What clears the 30% of LDL not cleared by the liver?
i. Adrenal and gonads-- LDL scavenges cholesterol for steroid hormones
ii. Macrophages
a. Where is HDL synthesized?
i. Liver and intestine
b. What are the characteristics of nascent HDL?
i. Disc-shaped
ii. Phospholipid rich
c. What are the apoproteins of nascent HDL from the liver?
i. AI
ii. AII
iii. apoE
iv. apoC
d. What are the apoproteins of nascent HDL from the intestine?
i. AI
e. What does HDL acquire in the bloodstream?
i. Cholesterol from outer leaflet of cells by ABCA1
ii. LCAT from plasma
iii. CETP from plasma
iv. Other apoproteins/lipoproteins
f. How does HDL dock to other cells?
i. apoAI
ii. apoE
g. How is HDL involved in reverse cholesterol transport?
i. HDL3 expresses a high LCAT activity
ii. LCAT removes cholesterol, converting it to cholesteryl ester
iii. HDL3 transfers CE to IDL and chylomicron remnants in exchange for phospholipid and TAGs
h. How does HDL3 become HDL2?
i. Acquiring more phospholipids and increasing in size through reverse cholesterol transport
i. For what is HDL2 a substrate?
i. HL→ hydrolyzes excess TAG and PL
j. How do SRB1 and HDL2 interact? What is the result of this interaction?
i. SRB1 of liver binds HDL2 and selectively transfers CE to liver cell
ii. HDL3 is regenerated from HDL2 in this manner
a. What causes abetalipoproteinemia?
i. Deficiency of a TAG transfer protein in ER
ii. Liver and intestine unable to assemble or secrete apoB-containing lipoproteins
b. What is absent in abetalipoproteinemia?
i. Chylomicrons
ii. VLDL
iii. LDL
c. What are the consequences of abetalipoproteinemia?
i. Severe fat malabsorption
ii. Accumulation of TAGs in intestine and liver
iii. Deficiencies of fat soluble vitamins
d. What will untreated patients of abetalipoproteinemia develop?
i. Ataxia
ii. Retinitis pigmentosa
iii. Myopathy
a. How do you tx abetalipoproteinemia?
i. Vitamin E
f. What causes Tangier disease?
i. Deficiency of ABCA1
g. What are the consequences of Tangier disease?
i. HDL cannot be formed
ii. Decreased LDL
iii. Cholesteryl ester deposits in RES, bone marrow, and Schwann cells
h. What are the symptoms of Tangier disease?
i. Peripheral neuropathy
ii. Hepatosplenomegaly
iii. LAD
iv. Mild tendency for early atherosclerosis
i. What is the cause of familial hypercholesterolemia?
i. Deficiency of LDL receptor
j. What is the average cholesterol level in familial hypercholesterolemia?
i. 350 mg/dL
k. What form of inheritance is more common in familial hypercholesterolemia?
i. Heterozygotes→ more severe form of disease
l. What are the consequences of familial hypercholesterolemia?
i. Accelerated CHD
ii. Homozygotes die by age of 20
m. What causes xanthomas?
i. Mutations in LDL receptor
n. What are the consequences of familial LCAT deficiency?
i. Block in reverse cholesterol transport
ii. Limited ability of HDL to acquire cholesterol from VLDL or chylomcirons
iii. Elevated blood cholesterol and TAGs
o. What are the symptoms of familial LCAT deficiency?
i. Free cholesterol accumulates in most tissues
ii. Kidney disease
iii. Corneal clouding
iv. Mild tendency for early atherosclerosis
p. What are the consequences of a CETP deficiency?
i. Benign
ii. Cholesteryl esters cannot be transferred from HDL to other lipoproteins
iii. Homozygotes have 4x elevation of HDL cholesterol
iv. LDL is normal or low
q. How is reverse cholesterol transport still possible in someone with a CETP deficiency?
i. SRB1 receptors of liver
ii. Endocytosis of HDL with multiple copies of apoE
a. What is the plasma lipid profile of type I hyperchylomicronemia?
a. Greatly increased TAGs
b. Cholesterol slightly elevated
c. Not associated with increased atherosclerosis
b. What causes type I hyperlipoproteinemia?
a. LPL deficiency
b. apoC-II deficiency
c. What are the symptoms of type I hyperlipoproteinemia?
a. Eruptive xanthomas
b. Abdominal pain after a fat-containing meal
c. Recurrent pancreatitis
d. What is the manifestation of type II hypercholesterolemia?
a. LDL elevation
b. Atherosclerosis is a major risk
e. What causes type II hypercholesterolemia?
a. Familial hypercholesterolemia
b. Obesity, diabetes (less common)
f. What is the plasma lipid profile of type III dysbetalipoproteinemia?
a. Increased TAGs
b. Increased cholesterol
g. What causes type III dysbetalipoproteinemia?
a. Homozygotes for apoE2
b. ApoE2 does not bind hepatic apoE receptors
c. Chylomicrons and VLDL remnants accumulate
h. What are the symptoms of dysbetalipoproteinemia?
a. Xanthomas
b. Increased risk of CHD
i. How do you tx dysbetalipoproteinemia?
a. Dietary changes
a. What is the plasma lipid profile of type IV/hypertriglyceridemia?
a. Increased TAGs
b. Hypercholesterolemia due to cholesterol content of VLDL
k. What causes type IV/hypertriglyceridemia?
a. Obesity
b. Type II diabetes
c. Progesterone-rich contraceptives
d. Excess dietary carbohydrates
l. What is the plasma lipid profile of type V/hyperlipoproteinemias?
a. Increased TAGs
b. Increased cholesterol
m. What is the cause of type V/hyperlipoproteinemias?
a. Increased chylomicrons and VLDL
b. Associated with uncontrolled diabetes, obesity, and kidney disease
n. How do you tx type V/hyperlipoproteinemias?
a. Dietary changes